| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,244 |
1,082 |
$131K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,402 |
1,187 |
$103K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,188 |
1,694 |
$93K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,881 |
1,398 |
$50K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,567 |
1,924 |
$46K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,945 |
1,521 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,773 |
1,151 |
$23K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,749 |
1,448 |
$19K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
510 |
427 |
$17K |
| 99051 |
|
1,002 |
842 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
253 |
206 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
507 |
253 |
$4K |
| 87807 |
|
311 |
255 |
$2K |
| 99000 |
|
579 |
547 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
172 |
133 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
158 |
146 |
$581.78 |
| 99201 |
|
41 |
30 |
$484.00 |
| 87070 |
|
44 |
40 |
$275.00 |
| 87081 |
|
20 |
13 |
$72.00 |
| 99441 |
|
189 |
165 |
$0.00 |
| A9150 |
Non-prescription drugs |
24 |
14 |
$0.00 |
| 99173 |
|
36 |
12 |
$0.00 |